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ABSTRACT 
The growing problems of tuberculosis have led to the search for new anti-Mtb agents from higher plants. The stem bark of 
Spondias mombin was evaluated for its in vitro activity against Mycobacterium tuberculosis (H37Rv strain). Bioassay-guided 
fractionation of the methanol extract was carried out by Vacuum Liquid Chromatography (VLC) on Silica gel (230-400 mesh) 
and purification was done using HPLC and TLC. In vitro antimycobacterial susceptibility was performed by a fluorometric 
microplate alamar blue assay (MABA) and percentage mycobacterial inhibition was calculated. The structures of the isolated 
compounds were established by spectroscopic analysis. The active VLC fraction exhibited 91% inhibition against M. tuberculosis 
H37Rv at a concentration of 40 µg/mL. The HPLC fraction SMi-15 containing compounds 1 and 2 showed 92.8% inhibition 
against M. tuberculosis. Two new antimycobacterial phytosterols were isolated from the stem bark of S. mombin and the 
structureswere identified as mombintane I (1) and mombintane II (2). The stem bark extractives of S. mombin contain 
antitubercular principles of the class phytosterol and support an important potential of triterpenoids. 
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INTRODUCTION 
1 
Spondias mombin is widely cultivated and naturalized in 
tropical Africa. A bark-slash exudes a clear sticky gum. 
Generally, each part of the plant has medicinal uses. A 
tea of the flowers and leaves is taken to relieve various 
inflammatory conditions and stomachache. The tea is 
also reputed to have wound healing potential (Burkill, 
1995; Villegas et al., 1997). The stem bark of S. mombin 
is used traditionally in West Africa for the treatment of 
cough and other respiratory disorders (Morton, 1987). 
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The phytochemical and pharmacological investigation 
of the leaf of S. mombin has been reported previously 
(Corthoutet al., 1991; Corthoutet al., 1992; Corthoutet 
al., 1994; Coates et al., 1994; Ayokaet al., 2006; Fred-
Jaiyesimi  et al,2009; Silva et al., 2011). We reported 
previously the antitubercular property of the stem bark 
fractions of S. mombin (Olugbuyiro et al., 2009). In the 
course of further study on the chemical constituents of 
an anti-Mtb fraction of S. mombin, we report herein the 
isolation and structural elucidation of two new active 
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phytosterols- mombintane I (1) and mombintane II (2) 
from the stem bark. 
 
MATERIALS AND METHODS 
 
General 
The methanol extract prepared from stem bark of S. 
mombin was analyzed by VLC (Si gel 230-400 mesh, 
Merck) and HPLC (Waters Prep LC system 4000). 
Characterization was done using TLC chromatography 
(Si gel 60 F254 plates), NMR (400 MHz, in CDCl3) and 
Mass spectroscopy (Bruker ESI-micrOTOF). 
Mycobaterium tuberculosis (H37Rv) was provided by 
Dr. S. Franzblau, College of Pharmacy, University of 
Illinois at Chicago. 
 
Plant material 
Spondiasmombin stem bark was collected in the 
environs of University of Ibadan, Nigeria in August, 
2007 and identified by Dr. O.A. Ugbogu of Forestry 
Research Institute of Nigeria, Ibadan. A voucher 
specimen (FHI NO. 107896) was deposited. 
 
Extraction and isolation 
Bioassay guided fractionation of the crude extract was 
done by Vacuum Liquid Chromatography (VLC) using 
normal phase conditions. VLC was performed on Si gel 
230-400 mesh (Merck) with gradient elution using 
hexane, EtOAc, MeOH and water in the order of 
increasing polarity. Eleven fractions were collected. The 
active portions VL2-3 were pooled and subjected to RP-
HPLC (Luna C8 column 21.2 x 250 mm) using a linear 
gradient from 85% water-15% acetonitrile to 100% 
methanol with flow rate 15ml/min. A total of 22 
fractions were collected and similar fractions were 
pooled based on their proton NMR profile and the HPLC 
chromatogram. Altogether, 12 fractions were obtained 
and submitted for anti-Mtb assay. One of the active 
fractions, SMi-15 (ACN/MeOH 78:22), was subjected to 
further purification by reversed-phase HPLC with C8 10 
x 250 mm; eluted with ACN/MeOH (90:10-100:0) at a 
flow rate of 3ml/min which gave rise to 5 compounds. 
SMi-15-4 (1) and SMi-15-5 (2) were selected for 
characterization based on the MS and proton NMR 
spectra. 
 
MicroplateAlamar Blue Assay (MABA) 
In vitro antimycobacterial activitywas evaluated against 
Mycobacterium tuberculosis H37Rv using the 
microplate Alamar blue assay (MABA) as previously 
described (Collins and Franzblau, 1997; Franzblau et al., 
1998). Antimicrobial susceptibility testing was 
performed in black, clear-bottomed, 96-well 
microplates(black view plates; Packard Instrument 
Company, Meriden, Conn.) in order to minimize 
background fluorescence. Outer perimeter wells were 
filled with sterile water to prevent dehydration in 
experimental wells. Initial drug dilutions were prepared 
in either dimethyl sulfoxide or distilled deionized water, 
and subsequent twofold dilutions were performed in 0.1 
ml of 7H9GC (no Tween 80) in the microplates. Inocula 
were initially diluted 1:2 in 7H9GC and 0.1 ml was 
added to wells which resulted in bacterial titers of1 x 106 
CFU/ml in plate wells for H37Rv. Wells containing drug 
only were used to detect autofluorescence of 
compounds. Additional control wells consisted of 
bacteria only (B) and medium only (M). Plates were 
incubated at 37°C. Starting at day 4 of incubation, 20 µl 
of 10 x alamar blue solution (Alamar 
Biosciences/Accumed, Westlake, Ohio) and 12.5 µl of 
20% Tween 80 were added to one B well and one M 
well, and plates were reincubated at 37°C. Wells were 
observed at 12 and 24 h for a color change from blue to 
pink and for a reading of ≥50,000 fluorescence units 
(FU). Fluorescence was measured in a Cytofluor II 
microplate fluorometer (PerSeptiveBiosystems, 
Framingham, Mass.) in bottom-reading mode with 
excitation at 530 nm and emission at 590 nm. If the B 
wells became pink by 24 h, reagent was added to the 
entire plate. If the well remained blue or ≤50,000 FU was 
measured, additional M and B wells were tested daily 
until a color change occurred, at which time reagents 
were added to all remaining wells. Plates were then 
incubated at 37°C, and results were recorded at 24 h 
post-reagent addition. Rifampicin was used as the 
reference drug. 
Percent inhibition was defined as 1 - (test well mean 
FU/mean FU of triplicate B wells) x 100. The lowest 
drug concentration effecting an inhibition of ≥90% was 
considered the MIC. 
 
RESULTS AND DISCUSSION 
 
The anti-Mtb active fraction purified by RP-HPLC 
resulted to two compounds (1 and 2).  Compound 1 was 
obtained as off-white amorphous solid by reversed-
phase HPLC with Luna C8 column. It was positive to 
Liebermann-Burchard test for a triterpene. 1H NMR 
spectrum of 1 showed characteristic signals (Table 1) 
assignable to a sterol moiety (Yayli and Baltaci; 1996; 
Chen et al., 1998; Kökdila et al. 2002; Yan et al. 2007). 
The DEPT NMR analysis showed six methyls, nine 
methylenes, and ten methines. In the down field region 
of the DEPT spectrum there were two peaks, at δC 149.4 
(C) and 121.8 ppm (CH) assignable to one olefinic bond 
which is located at Δ9 position.  
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Fig. 1a.  
Compound 1- Mombintane I [Stigmasta-9-en-3, 6, 7-triol]: Isolated as off-white amorphous solid (1.8mg) Rf 0.80; 1H- NMR (CDCl3, 400 
MHz): δ ppm 5.37 (1H, H-11), 3.68 (1H, H-7), 3.52 (1H, H-6), 3.50 (1H, H-3), 2.40 (1H, s, 3-OH), 2.35 (1H, s, 6-OH), 2.33 (1H, s, 7-OH), 
2.02 (1H,  H-8), 2.01(2H,  H-12), 1.98 (1H H-25), 1.64 (1H, H-20), 1.59 (2H, H-2), 1.57 (2H, H-4), 1.55 (1H, H-5), 1.53 (1H, H-14), 1.47 (2H, 
H-15), 1.47 (2H, H-16), 1.47 (1H, H-17), 1.46 (1H), 1.40 (1H, H-1), 1.29 (2H, H-28), 1.26 (3H, H-19),  1.25 (2H, H-22), 1.25 (1H, H-23), 1.17 
(3H, s, H-18), 1.26 (3H, s, H-19), 1.10 (3H, s, H-21), 0.87 (3H, H-29), 0.90 (3H, H-26), 0.90 (3H, H-27). 13C- NMR (CDCl3, 400 MHz): δ ppm 
149.4 (C-9), 121.8 (C-11), 84.4 (C-7), 75.5 (C-6), 73.8 (C-3), 51.3 (C-17), 50.1 (C-14), 46.0 (C-24), 41.3  (C-13), 38.6 (C-12),  35.6 (C-5), 
34.1 (C-10), 33.7 (C-22), 31.9 (C-8), 30.0 (C-2), 30.0 (C-25), 29.7 (C-20), 29.6 (C-23), 29.2 (C-4), 27.2 (C-1), 25.6 (C-28), 24.7 (C-15), 24.7(C-
20),   22.6 (C-16), 21.0 (C-18), 21.1 (C-19), 19.3 (C-26), 19.2 (C-27), 18.2 (C-21), 14.1 (C-29). ESI-MS m/z 447 [M - H]-, 430 [M-OH]-, 413 
[M-H-2H2O]-, HRESIMS m/z 446.3197 [M-H]-, (calcd for C29H52O3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1b.  
Compound  2- Mombintane II [3-hydroxy, 22-epoxystigmastane]: Isolated as off-white amorphous solid (1.7mg) Rf 0.86; 1H- NMR (CDCl3, 
400 MHz): δ ppm 4.24 (1H, H-22),  4.22 (1H, H-16),  3.68 (1H, H-20),   3.50 (1H, H-3),  2.30 (1H, H-25), 2.29 (1H, H-17), 2.01 (3-OH),  1.66 
(2H, H-15), 1.62 (1H, H-2), 1.54 (2H, H-4), 1.47 (1H, H-24), 1.41 (1H, H-5), 1.41 (1H, H-8),  1.40 (2H, H-6), 1.40 (2H, H-7), 1.40 (1H, H- 9), 
1.40 (2H, H-11), 1.40 (1H, H-14),  1.37 (2H, H-1), 1.37 (2H, H-12), 1.29 (2H, H-28), 1.21 (3H, s, H-18), 1.21 (3H, s, H-19), 1.06 (3H, s, H-
21), 0.92 (3H, s, H-26), 0.90 (3H, s, H-27), 0.88 (3H, s, H-29). 13C-NMR (CDCl3, 400 MHz): δ ppm 99.9 (C-22), 73.1 (C-16), 68.1 (C-3), 55.7 
(C-9), 55.6 (C-17), 47.0 (C-14), 45.4 (C-12), 41.4 (C-5), 40.2 (C-24), 37.0 (C-10), 36.8 (C-4), 36.8 (C-13), 36.0 (C-8), 34.0 (C-1), 33.0 (C-23), 
31.9 (C-7), 30.9 (C-25), 30.2 (C-2), 29.5 (C-6), 29.5 (C-15), 29.5 (C-20), 26.2 (C-28), 22.1 (C-11), 21.0 (C-26), 21.0 (C-27), 12.6 (C-18), 12.4 
(C-19), 12.2 (C-21), 12.2 (C-29). ESI-MS m/z 430 [M - H]-, 413 [M-OH]- HRESIMS m/z 430.3199 [M-H]-, (calcd for C29H50O2).  
 
This is supported by the presence of olefinic proton 
signal at δH 5.3 (1H) ppm. The existence of molecular 
ion peaks at m/z 447, m/z 430 and m/z 413 inferred loss 
of two hydroxyl groups in succession from MS analysis 
and this established the presence of two additional 
hydroxyl groups on the stigmastane nucleus. The 
presence of proton signals at δ 2.35 (6-OH) and δ 2.33 
(7-OH) also gave credence to the presence of two OH 
groups. The ESI-MS spectrum displayed molecular ion 
at m/z 413 [M-H]- common to stigmasterol. The 
molecular formula of compound 1, C29H50O3, was 
established via HRESIMS and the spectroscopic data 
was compared with those reported in the literature 
(Silverstein et al., 1991; Yayli and Baltaci; 1996; Chen 
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et al., 1998; Kökdila et al., 2002 and Yan et al., 2007). 
Compound 1 was identified as stigmasta-9-ene-3, 6, 7-
triol and the name mombintane I is proposed for 
compound 1, 
 
Table 1. 
 1H and 13C NMR data for 1 (400 MHz , CDCl3, J in Hertz and 
δ in ppm) 
C/H 
No 
δC δH C δC δH 
1 27.2 1.40 (2H)  18 21.0 1.17(3H, s)  
2 30.0 1.59 (2H)  19 21.1 1.26 (3H, s )  
3 73.8 3.50 (1H)  20 29.7  1.64 (1H ) 
4 29.2 1.57 (2H) 21 18.2 1.10 (3H, s)  
5 35.6 1.55 (1H) 22 33.7 1.26 (2H)  
6 75.5  3.52 (1H)  23 29.6  1.26 (2H) 
7 84.4 3.68 (1H)  24 46.0 1.46 (1H)  
8 31.9 2.02 (1H ) 25  30.0 1.98 (1H) 
9 149.4 -  26 19.3 0.90 (3H, s) 
10 34.1 -  27 19.2 0.90 (3H, s) 
11 121.8 5.37 (1H) 28 25.6 1.29 (2H) 
12 38.6 2.02 (2H)  29 14.1 0.87 (3H, s)  
13 41.3 - 3-OH  2.40 (1H, s)  
14 50.1 1.53 (1H)  6-OH  2.35 (1H,s)  
15 24.7  1.47 (2H ) 7-OH  2.33 (1H ,s)  
16 22.6 1.47 (2H )    
17 51.3 1.47 (1H )    
 
 Compound 2 was obtained off-white amorphous 
solid by reversed-phase HPLC with Luna C8 column. It 
was also positive to Liebermann-Burchard test for a 
triterpene. Its molecular formula, C29H50O2, was 
established by HRESIMS, 13C NMR and DEPT 
spectroscopic data. 1H NMR spectrum of 2 showed 
characteristic signals (Table 2) assignable to a sterol   
(Yayli and Baltaci; 1996; Chen et al., 1998; Kökdila et 
al. 2002, Yan et al. 2007). The DEPT NMR analysis 
showed six methyls, ten methylenes, eleven methines 
and two non-protonated carbon resonances assignable to 
stigmastane nucleus. In comparison with compound 1 
however, there was absence of the olefinic bond in the 
down field region of both 13C and 1H spectra of 2. The 
oxygenated carbon resonance at δC 68.1 revealed the 
presence of one hydroxyl group as supported by the 
proton NMR signals at δH 3.50 (H-3) while the signals at 
δC 99.9 (C-22) and 73.1 (C-16)  could only be 
accommodated  with  the formation of a five membered 
ring E (tetrahydro furan) leading to 22-epoxycholestane 
of furostans class. The highly deshielded protons at δH 
4.24-4.22 (H-16 and H-22) lent a support to the presence 
of an epoxide at C-22. The ESI-MS molecular ions in 
negative mode at m/z 430 [M - H]- and 413 [M-OH]- 
confirmed the  fragment ions common to sterols (Yayli 
and Baltaci; 1996; Chen et al., 1998). Finally, high 
resolution mass measurement gave a molecular formula 
corresponding with C29H50O2. The spectroscopic data 
suggested that the isolated molecule was furostan (2). 
Compound 2 was identified as 3-hydroxy-22-
epoxystigmastane by comparison of its 1H- and 13C -
NMR and MS data with those reported in the literature 
(Yayli and Baltaci; 1996; Chen et al., 1998; Kökdila et 
al. 2002, Yan et al., 2007; DNP, 2011) and named 
mombintane II. 
 
Table 2.  
1H and 13C NMR data for 2 (400 MHz , CDCl3, J in Hertz and 
δ in ppm) 
C/H 
No 
δC δH C/H 
No. 
δC δH 
1  34.0  1.37 (2H)  16  73.1 4.22 (1H)  
2  30.2  1.62 (2H)  17  55.6 2.29 (1H)  
3  68.1 3.50 (1H)  18  12.6  1.21 (3H)  
4  36.8 1.54 (2H) 19  12.4  1.21 (3H)  
5  41.4 1.41 (1H)  20  29.5 3.68 (1H)  
6  29.5  1.40 (2H)  21  12.2 1.06 (3H)  
7 31.9 1.40 (2H)  22  99.9 4.24 (1H)  
8  36.0  1.41 (1H)  22’ O -- 
9  55.7 1.40 (1H)  23  33.0 1.39 (2H) 
10  37.0 --  24  40.2 1.47 (1H)  
11  22.1  1.40 (2H)  25  30.9  2.30  (1H)  
12  45.4 1.37 (2H)  26  21.0 0.92 (3H)  
13  36.8  --  27  21.0 0.90 (3H)  
14  47.0  1.40 (1H)  28  26.2 1.29 (2H)  
15  29.5 1.66 (2H)  29 12.2 0.88 (3H)  
   3-OH   2.01 (1H, s) 
 
 Antibacterial activity is one of the cited biological 
properties displayed by triterpenoids. Knowltonia 
vesicatoria was reported (Labuschagné et al., 2012) to 
possess antimycobacterial property. Two active 
triterpenoids, stigmasta-5, 23-dien-3-ol and 5-
(hydroxymethyl)furan-2(5H)-one, were isolated from K. 
vesicatoria and stigmasta-5,23-dien-3-ol was found 
active against a drug-sensitive strain of Mtb with a MIC 
of 50.00 μg/mL.  The triterpene, 23-hydroxy-5a-lanosta- 
7, 9 (11), 24-triene-3-one, has been demonstrated active 
against sensitive strain of M. tuberculosis with MIC 
value of 12.5 μg/mL among thirty five tested plant 
products (Camacho-Corona, 1998). In this study, the in 
vitro antimycobacterial susceptibility against M. 
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tuberculosis H37Rv showed that the crude extract had 
27% inhibition. The crude extract potency was enhanced 
by purification as reflected by the most active VLC 
fraction (Table 3), which exhibited 91% inhibition 
against M. tuberculosis. HPLC fraction SMi-15 
containing compounds 1 and 2 showed 92.8% inhibition 
while the reference rifampicin had 99.7% inhibition. The 
findings identified two new anti-Mtb compounds of 
phytosterol class and support an important potential of 
triterpenoids as previously published in literature. This 
suggests S. mombin as a potential anti-Mtb plant for 
generating leads that may be useful for the treatment of 
tuberculosis.  
 
Table 3.  
Antimycobacterial activity of the VLC column fractions 
of S. mombin stem bark 
# Sample  % Inhibition  
1 VL1 2  
2 VL2 91  
3 VL3 69  
4 VL4 32  
5 VL5 26  
6 VL6 27  
7 VL7 27  
8 VL8 13  
9 VL9 24  
10 VL10 8  
11 VL11 22  
  Drug control   
 RMP 99  
 INH 94  
 M.TB strains: H37RV,  
Inhibition of ≥ 90% was considered active,  
Assays run @ 40 μg/ml  
INH= isoniazid, RMP= rifampicin 
 
Conclusion 
Two new antimycobacterial phytosterols were isolated 
from the stem bark of Spondias mombin. The 
compounds were identified as stigmasta-9-ene-3,6,7-
triol and 3-hydroxy-22-epoxystigmastane by means of 
spectroscopic analysis. This is the first report of isolation 
of these phytosterols from Spondias mombin.  
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